Medical news
-
WFH Notice: Global recall of Octim®/Octostim® desmopressin nasal spray (1.5 mg/ml) by Ferring Pharmaceuticals
Update to WFH Notice: recall of desmopressin nasal spray by Ferring Pharmaceuticals (July 20, 2020) August 4, 2020 In mid-July, Ferring Pharmaceuticals initiated a voluntary precautionary...
-
Now published: The WFH Guidelines for the Management of Hemophilia, 3rd edition
This 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia offers up-to-date guidance and practical recommendations on the diagnosis and management...
-
WFH Notice: recall of desmopressin nasal spray by Ferring Pharmaceuticals
July 20, 2020 The WFH has learned of a voluntary product recall of desmopressin nasal spray by Ferring Pharmaceuticals, due to out of specification results...
-
Joint WFH and NHF statement issued regarding two deaths reported in orphan disease gene therapy clinical trial
A joint World Federation of Hemophilia (WFH) and National Hemophilia Foundation (NHF) statement* is issued on two deaths reported in orphan disease gene therapy clinical...
-
20-year progress and findings of WFH Annual Global Survey published in Haemophilia
The World Federation of Hemophilia (WFH) Annual Global Survey (AGS) was launched to standardize the collection of data on the global bleeding disorder population. The...
-
Coming soon: Hemophilia Guidelines for all – a new ambition of the WFH
The 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia is coming soon. This invaluable resource will offer up-to-date...
-
Earn CME credits at the WFH Virtual Summit
The WFH Virtual Summit: Connecting the Global Bleeding Disorders Community, being held from June 14 to 19, 2020, has been accredited by the European Accreditation...
-
Article on WFH Gene Therapy Registry published in Haemophilia
A new commentary presenting the World Federation of Hemophilia (WFH) Gene Therapy Registry has been published in Haemophilia, the official journal of the WFH. The...
-
Role of telemedicine during the COVID‐19 pandemic analysed in Haemophilia
A new letter to the editor, published in Haemophilia, the official journal of the World Federation of Hemophilia (WFH), looks at how healthcare practitioners are...
-
Practical guidance for the in‐hospital management of PWH published in Haemophilia
In‐hospital management of persons with haemophilia and COVID‐19: practical guidance, authored by Cedric Hermans, MD, Medical member, WFH Board of Directors, has just been published...
